Koch E
Arzneimittelforschung. 1976 Apr;26(4b):686-9.
The profile of the spasmolytic 4,4-diphenyl-N-isopropyl-cyclohexylamine-hydrochloride (pramiverine, Sistalgin) is outlined on the basis of fundamental research. Evidence is provided that a combination with metamizole is useful in the case of Sistalgin comp. Description of the clinical and clinico-experimental examinations confirmed the margin of indications for Sistalgin and Sistalgin comp. Reference is made to the applications with a view to facilitate endoscopic and radiological procedures. The tabulated list of 2368 patients demonstrates the positive ratio between therapeutic effect and undesirable cholinolytic concomitant effect of Sistalgin comp.
基于基础研究概述了解痉药4,4-二苯基-N-异丙基环己胺盐酸盐（普拉米维林，西斯塔金）的概况。有证据表明，西斯塔金复方制剂与安乃近联合使用是有效的。临床和临床实验检查的描述证实了西斯塔金和西斯塔金复方制剂的适应证范围。提及了其应用，以便于进行内镜和放射学检查。2368例患者的列表显示了西斯塔金复方制剂治疗效果与不良抗胆碱能伴随效应之间的阳性比率。
